September 5, 2024 02:44 PM EDT
Pharma
Law

J&J in­creas­es talc set­tle­ment by $1.1B af­ter ne­go­ti­at­ing with plain­tiffs, lawyers say

Nicole DeFeudis

Editor

John­son & John­son agreed to in­crease its talc set­tle­ment plan by $1.1 bil­lion af­ter ne­go­ti­at­ing with plain­tiffs’ lawyers, ac­cord­ing to one of the at­tor­neys. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

A service from the Financial Times